Leveraging immuno-fluorescence data to reduce pathologist annotation requirements in lung tumor segmentation using

Hatef Mehrabian1, Jens Brodbeck2, Peipei Lyu2

  • 1Non-Clinical Safety and Pathobiology, Gilead Sciences, Foster City, CA, USA. hatef.mehrabian@gilead.com.

Scientific Reports
|September 16, 2024
PubMed

Related Concept Videos